Gufic Biosciences has been granted patent by the Eurasian Patent office (EAPO) for its invention of ‘A Freeze Dried Parenteral Composition of Tigecycline and Process for Preparation Thereof’. Tigecycline is a tetracycline antibiotic medication used for a number of bacterial infections and is used to treat certain serious infections including community acquired pneumonia (a lung infection that developed in a person who was not in the hospital), skin infections, and infections of the abdomen.
Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.
